{
  "id": 1312,
  "text": "Patients in the NACT group were then randomly assigned to be treated with irinotecan plus cisplatin followed by surgery or to be treated with paclitaxel plus cisplatin followed by surgery.Here again, no significant difference in DFS or OS between the two treatment groups were reported.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Patients in the NACT group were then randomly assigned to be treated with irinotecan plus cisplatin followed by surgery or to be treated with paclitaxel plus cisplatin followed by surgery.Here again, no significant difference in DFS or OS between the two treatment groups were reported.\n\n<question>: ",
  "ChatGPT_response_0": "在选择依立曲班加顺铂还是紫杉醇加顺铂的治疗方案时，我们需要综合考虑患者的具体情况和临床研究的数据。根据相关研究结果显示，这两种治疗方案在患者的无病生存期（DFS）和总生存期（OS）方面并没有显著差异。因此，选择哪种方案取决于患者的个体情况、疾病特点以及医生的建议。在制定治疗方案时，应综合考虑各种因素，以达到最佳的治疗效果。",
  "query": "在治疗过程中，您更倾向于选择使用依立曲班加顺铂还是紫杉醇加顺铂的方案，并为何？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在治疗过程中，您更倾向于选择使用依立曲班加顺铂还是紫杉醇加顺铂的方案，并为何？\n\n<reference text>: Patients in the NACT group were then randomly assigned to be treated with irinotecan plus cisplatin followed by surgery or to be treated with paclitaxel plus cisplatin followed by surgery.Here again, no significant difference in DFS or OS between the two treatment groups were reported.\n\n<reply>: ",
  "response": "在选择依立曲班加顺铂还是紫杉醇加顺铂的治疗方案时，我们需要综合考虑患者的具体情况和临床研究的数据。根据相关研究结果显示，这两种治疗方案在患者的无病生存期（DFS）和总生存期（OS）方面并没有显著差异。因此，选择哪种方案取决于患者的个体情况、疾病特点以及医生的建议。在制定治疗方案时，应综合考虑各种因素，以达到最佳的治疗效果。"
}